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Abstract 
Background: While nanotechnology is advancing rapidly, nanosafety tends to lag behind since general mechanistic 
insights into cell-nanoparticle (NP) interactions remain rare. To tackle this issue, standardization of nanosafety assess-
ment is imperative. In this regard, we believe that the cell type selection should not be overlooked since the applica-
bility of cell lines could be questioned given their altered phenotype. Hence, we evaluated the impact of the cell type 
on in vitro nanosafety evaluations in a human and murine neuroblastoma cell line, neural progenitor cell line and in 
neural stem cells. Acute toxicity was evaluated for gold, silver and iron oxide (IO)NPs, and the latter were additionally 
subjected to a multiparametric analysis to assess sublethal effects.
Results: The stem cells and murine neuroblastoma cell line respectively showed most and least acute cytotoxicity. 
Using high content imaging, we observed cell type- and species-specific responses to the IONPs on the level of reac-
tive oxygen species production, calcium homeostasis, mitochondrial integrity and cell morphology, indicating that 
cellular homeostasis is impaired in distinct ways.
Conclusions: Our data reveal cell type-specific toxicity profiles and demonstrate that a single cell line or toxicity end 
point will not provide sufficient information on in vitro nanosafety. We propose to identify a set of standard cell lines 
for screening purposes and to select cell types for detailed nanosafety studies based on the intended application 
and/or expected exposure.
Keywords: Nanosafety, High content imaging, Inorganic nanoparticles, Iron oxide nanoparticles, Stem cells, 
Multiparametric analysis
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Background
In recent years, many inorganic nanoparticles (NPs) have 
made their way to the market as they are being incor-
porated into various consumer products [1]. Moreover, 
their unique properties are being extensively explored for 
various biomedical applications. For instance, gold NPs 
(AuNPs) and iron oxide NPs (IONPs) hold great promise 
as theranostic agents for cancer treatment through 
hyperthermia combined with tumour detection via 
respectively photoacoustic or magnetic resonance imag-
ing [2]. Additionally, silver NPs (AgNPs) are good can-
didates for wound dressings and antibacterial coatings 
of medical devices due to their enhanced antimicrobial 
properties [3]. However, to date only a few nano-enabled 
products were successfully translated into the clinic. 
Besides general targeting issues, this can primarily be 
attributed to their elusive safety profiles [4]. Despite 
extensive efforts, a general paradigm on how inorganic 
NPs are able to affect homeostasis on the level of the cell, 
organ or organism and to which physicochemical NP 
properties this can be attributed, is largely lacking [5].
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In general, nanosafety evaluations struggle with two 
important obstacles. The first is the fast pace at which 
nanotechnology keeps advancing, leading to the develop-
ment of a plethora of NPs with distinct physicochemical 
properties, which should ideally undergo safety evalua-
tion prior to their (biomedical) implementation. The sec-
ond is the lack of standardization of in vitro nanosafety 
studies, as various groups apply different assays on vari-
ous cell types. This results in low inter-study compa-
rability and the publication of conflicting data, which 
complicates the elucidation of general paradigms on NP-
cell interactions [6, 7].
The first hurdle can be overcome by implementing high 
throughput or high content techniques in order to speed 
up in vitro nanosafety testing [8, 9]. Secondly, much effort 
is being put into the standardization of various factors 
of in vitro nanosafety studies [10, 11]. In this regard, we 
believe that the cell type selection should receive equal 
attention. In most studies a cell line is selected since they 
are in general more readily accessible, less expensive 
and easier to cultivate when compared to primary cells 
[7, 12]. However, cancer cell lines have a disturbed anti-
apoptotic balance as well as an altered metabolism to 
sustain their high proliferation rate [13]. The phenotype 
expressed by immortalized cells is in turn not entirely 
stable and might undergo changes due to the extensive 
in vitro manipulation or the initial immortalization [14]. 
Hence, a shift towards the use of primary or stem cells 
as well as more complex cell culture models for in vitro 
nanosafety testing strategies could be noted recently. In 
contrast, primary cells can suffer from clonal variations 
and have a limited lifespan in vitro, making rational cell 
type selection a balancing act [7].
Subsequent to the realization that the cell type could 
be of substantial importance, several groups have shown 
that NP-induced effects vary in cell lines retrieved from 
different tissues or species [15–18]. On the contrary, only 
a few studies compared NP effects in a cancer or immor-
talized cell line versus primary cells representing the 
same tissue and species [19, 20]. Unfortunately, available 
data contrast one another wherefore no unambiguous 
conclusions could yet be formulated on whether cell lines 
can generally be applied as a reliable model for in  vitro 
nanosafety studies. In addition, many of the abovemen-
tioned reports choose to either focus on interspecies 
variations or cell-type related differences in NP-evoked 
effects and do not address both factors in a single study.
Here, we present a side-by-side comparison of NP-
evoked effects in six related neural cell types thereby 
evaluating the extent of both species and cell type related 
variations in NP-induced cytotoxicity. We selected a neu-
roblastoma cell line, neural progenitor cell line and neural 
stem cells derived from either humans or mice (Table 1) 
and purposely applied the optimal culture conditions for 
each cell type. These cell types were selected as potential 
models to assess the safety of neural stem cell labeling 
with nanosized contrast agents prior to transplantation 
in the context of regenerative medicine [21–23]. In turn, 
the synthesized AuNPs, AgNPs and IONPs had a diam-
eter below 10 nm, making them good candidates for the 
proposed application [24]. First, we surveyed the acute 
toxicity of AuNPs, AgNPs and IONPs in all cell types. 
Subsequently we selected the IONPs for further evalua-
tion given the minor acute toxicity. Hereto we applied a 
validated multiparametric approach, using automated 
imaging, to evaluate the effect of sublethal doses on the 
production of reactive oxygen species (ROS), the calcium 
(Ca2+) homeostasis, mitochondrial health and cell mor-
phology [25]. Importantly, our data reveal distinct and cell 
type specific toxicity profiles that warrant careful selec-
tion of appropriate cell models for future nanosafety stud-
ies, taking both species and target tissue into account, and 
caution misinterpretation of experimental results based 
on a single cell type and/or toxicity end point.
Results and discussion
Synthesized inorganic NPs display similar physicochemical 
characteristics
AuNP, AgNP and IONP synthesis was initiated with 
the aim of obtaining a similar core diameter. All NPs 
had a mean core diameter around 3.8  nm, as meas-
ured by transmission electron microscopy (Additional 
file 1: Figure S4). Subsequently all NPs were coated with 
poly(isobutylene-alt-maleic anhydride) grafted with 
dodecylamine (PMA), which was selected as it ensures 
colloidal stability over a wide pH range and a uniform 
coating of the different core materials [31]. Dynamic 
light scattering measurements in water showed a hydro-
dynamic diameter of 9.0, 8.9 and 12.3  nm and a nega-
tive zeta-potential around −45, −35, and −54  mV for 
the coated AuNPs, AgNPs and IONPs respectively. All 
obtained values correspond well to data reported on the 
characterization of NPs synthesized via similar protocols 
[32, 33]. The NPs were synthesized with the intention of 
obtaining similar physicochemical properties so that dis-
crepancies in cell responses could be related to variations 
between the cell types. Additional characterization data 
on the plasmon resonance peaks, molecular extinction 
coefficients, initial NP dispersion concentrations, and 
Table 1 Cell types applied in this study
Stem cells Progenitor cell line Cancer cell line
Human hNSC [26] ReNcell [27] LA-N-2 [28]
Mouse mNSC [26] C17.2 [29] Neuro-2a [30]
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electrophoretic mobility can be found in Additional file 1: 
Figures S5, S6 and Tables S1, S2.
Acute toxicity depends on both the NP core material 
and the cell type
In initial cell experiments, we evaluated cell viability fol-
lowing 24 h NP exposure with the CellTiter GLO® assay. 
In Fig.  1, a general concentration-dependent decrease 
in ATP signal can be observed for every evaluated 
NP—cell type combination. Although the extent of this 
decrease clearly varies, the onset of this downward trend 
depended on both the applied NP and the cell type. In all 
cell types, the most severe effect was observed following 
AuNP treatment, while the cells were least affected by the 
IONPs. The toxicity observed for the AgNPs can likely in 
part be explained in terms of Ag+-ion leaching [34]. In 
turn, the severe acute cytotoxicity induced by the AuNPs 
could possibly be attributed to genotoxicity due to direct 
interactions between the 3.8  nm diameter AuNPs and 
DNA [35]. In addition, note that determining NP con-
centrations is not straightforward, as various methods/
models need to be applied for different NP materials 
(Additional file  1). This may affect the comparison of 
absolute concentrations of NPs of different materials and 
may additionally explain the severe toxicity observed 
here for the AuNPs. Given the limited loss of cell viability 
observed for the IONPs, the latter were selected for fur-
ther evaluation of sublethal effects.
Independent of the core material, the Neuro-2a cells 
were least susceptible to NP exposure whereas the hNSC, 
followed by the mNSC, were most sensitive. The suscep-
tibility ranking for the other cell types varied with the 
NP core material. This greater sensitivity of the NSC, 
as found under the conditions reported here, is dissim-
ilar to several studies where cell lines were found to be 
more susceptible to NP-induced acute cell injury [18, 
19]. However, our data correlate well with previous work 
from Bregoli et  al. [14] who did not observe any toxic 
effects in several hematopoietic cell lines, while primary 
bone marrow cells were clearly affected. Similar observa-
tions were recorded by Wilkinson et  al. and Schlinkert 
et al. who independently found normal bronchial epithe-
lial cells to experience more acute toxicity than the A549 
cancer cell line [36, 37].
ROS induction is observed in two out of six cell types
Since we found the IONPs to induce the least acute cell 
damage, it was decided to probe for sublethal effects 
caused by these NPs using a multiparametric methodol-
ogy. The evaluation of effects on cell function has become 
crucial, as it is generally recognized that nanosafety 
evaluations should go beyond live/dead scoring in order 
Fig. 1 A concentration-dependent decrease in ATP content, as measured via the CellTiter GLO® assay, is observed for every NP-cell type combina-
tion tested. Results for the AuNPs (yellow), AgNPs (blue) and IONPs (red) are represented as mean ± standard error of the mean (SEM, n = 3,). Statisti-
cal significance is indicated when appropriate for each type of NP in the corresponding color of the graphs [*p < 0.05, AuNPs (yellow), AgNPs (blue) 
and IONPs (red)]
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to establish a more predictive paradigm [15, 38]. Subtle 
changes in cell function might indeed be more predic-
tive towards in vivo adverse outcomes. For instance, NP-
promoted reactive oxygen species (ROS) production in 
pulmonary cells has been linked to acute inflammation 
in the lung [39, 40]. ROS induction is also stated to be 
the main mechanism via which metallic NPs induce cell 
stress. Persisting ROS induction can subsequently lead to 
oxidative stress and damage cellular components such as 
DNA, proteins and membrane lipids [6].
Upon IONP treatment, we observed an increased ROS 
production in two out of six cell types, namely the mNSC 
and human ReNcells (Fig. 2). In all other four cell types, 
ROS production was significantly reduced. Notably, for 
both the reduced or increased ROS levels, the effect was 
most outspoken in the NSC. Again the murine neuro-
blastoma cell line (Neuro-2a) was least affected in terms 
of ROS. Given the variable effects, no general statements 
can be made on whether the human or murine cell types 
were more severely affected than their counterparts.
Although ROS induction by IONPs is often observed 
[19, 39, 41], it has been shown that NP-induced cytotox-
icity cannot always be attributed to an increased ROS 
production [42]. Interestingly, Harris et  al. also wit-
nessed reduced ROS levels in their high content analy-
sis of IONP-induced effects on a mammalian fibroblast 
cell line [6]. Additionally, IONPs can exhibit an intrinsic 
peroxidase-like activity in mesenchymal stem cells and 
thus reduce the cellular ROS content, especially of H2O2 
[43, 44]. As this effect was only witnessed when IONPs 
remained intact, IONP biocompatibility is presumably 
to a large extent affected by the intracellular location 
and the way the cell processes the IONPs. In confirma-
tion, Sabella et  al. [45] found greater cell perturbation 
by metallic NPs when they were trafficked to the acidic 
lysosomes in comparison to the same NPs present in the 
cytoplasm, due to the enhanced degradation in the acidic 
compartments. Indeed, this degradation will be account-
able for an increased amount of free iron ions, which may 
in turn enhance ROS production via for instance Fenton 
chemistry [6, 46]. A final factor that could clarify our 
observation is the intrinsically different anti-oxidative 
capacity of the various cell types [15, 17]. Thus, the cell 
itself likely determines NP biocompatibility to a large 
extent.
IONP exposure perturbs cellular calcium homeostasis
Subsequently, we evaluated the effect of IONP exposure 
on the Ca2+ homeostasis. The intracellular free Ca2+ 
concentration ([Ca2+]c) is a valuable toxicity marker 
since Ca2+ is involved in a plethora of processes such 
as cell proliferation, mitochondrial function and gene 
Fig. 2 Effects on ROS production following IONP exposure visualized with the the CellROX® green probe. A significant induction of ROS production 
was observed in the mNSC and human ReNcells. In the other four cell types a significant reduction was observed. Statistical significance is indicated 
when appropriate (*p < 0.05). NTC not treated control
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expression [47, 48]. Ca2+ is furthermore of ultimate 
importance for proper cell function in neural cells, as it is 
required for neurotransmitter release and cellular excita-
bility [8, 49]. Additionally, Ca2+ is since long known to be 
an important regulator of cell death, where a significant 
increase in [Ca2+]c is noted [47]. A mild reduction can on 
the contrary be correlated with an impaired cell function 
due to enhanced intracellular Ca2+ storage or efflux in an 
effort to retain cell homeostasis, while cell lysis is corre-
lated to a more severe decrease [48, 50].
On the one hand, a significant concentration-depend-
ent increase in [Ca2+]c was observed in the hNSC, 
ReNcells, and C17.2 cells (Fig.  3). The effect was more 
severe in the progenitor cell lines compared to the hNSC 
and the ReNcells showed the highest [Ca2+]c. On the 
other hand, a decline of the [Ca2+]c was detected in the 
mNSC, LA-N-2 and Neuro-2a cells. In contrast to previ-
ous parameters, the Neuro-2a cells showed more severe 
effects in terms of the perturbation of the calcium home-
ostasis. Again, no unambiguous conclusions could be 
drawn on whether human or murine cell types are more 
sensitive towards NP exposure.
Multiple studies investigating the influence of NP 
exposure on the Ca2+ homeostasis also found [Ca2+]c 
to be augmented [51]. Since this response could be 
interpreted as a cell death signal, this outcome could be 
correlated to the initially observed acute toxicity (Fig. 1) 
[47, 52]. Although we would have expected to observe 
a greater increase in [Ca2+]c in the hNSC when com-
pared to the ReNcells based on the acute toxicity data, 
the opposite was true. In line with the observed decline 
in [Ca2+]c in three out of six cell types, Haase et  al. [3] 
documented diminished Ca2+ responses at cytotoxic 
NP doses in mNSC. This observation could on the one 
hand be explained in terms of cell lysis. On the other 
hand, stressed cells can maintain their Ca2+ homeostasis 
by elevating Ca2+ efflux via the plasma membrane Ca2+ 
ATPase pump [50]. We hypothesized that this occurred 
in the neuroblastoma cell lines where ATP levels were to 
a minor extent reduced and thus still allowed sufficient 
pump function.
In general, two groups could be distinguished based on 
the elevation or diminution of [Ca2+]c. Even though simi-
lar trends were retrieved in each group, it is clear that the 
extent of the perturbation of cellular Ca2+ homeostasis 
varied with the cell type. Since Ca2+ homeostasis is sig-
nificantly altered upon cell transformation or immor-
talization in favour of cell proliferation [53], it was not 
surprising that NP exposure variably altered the [Ca2+]c. 
Notably, cell type specific toxicity profiles started to 
emerge as various combinations of the thus far evaluated 
effects were obtained.
Fig. 3 Effect on [Ca2+]c as determined following labelling with Rhod-2 AM. A significant increase in [Ca
2+]c was observed in the hNSC and both 
progenitor cell lines whereas a significant reduction was observed in the remaining three cell types (p < 0.05). Statistical significance is indicated 
when appropriate (*p < 0.05). NTC not treated control
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Mitochondria are affected by IONP loading
Next, the effect of IONP exposure on mitochondrial 
homeostasis was evaluated. The mitochondria are inter-
esting organelles as they are the cell’s main energy sup-
pliers, involved in programmed cell death, an important 
source of ROS and to a large extent regulated by Ca2+ [52, 
54]. This Ca2+-mediated regulation is furthermore influ-
enced by external stimuli: in combination with a stress 
inducer Ca2+ promotes ROS production and possibly cell 
death, whereas under physiological conditions Ca2+ stim-
ulates the oxidative respiration in the mitochondria and 
thus ATP production [52]. Interestingly, the importance 
of oxidative respiration for overall cellular ATP produc-
tion varies with the cell type: both cancer cells and stem 
cells rather rely on cytosolic glycosylation for their ATP 
production [54, 55]. Hence, it is conceivable that mito-
chondria will not only be differentially affected, but also 
that the impact of mitochondrial perturbation on overall 
cell homeostasis will vary in the different cell types.
To visualize the mitochondria, we selected a probe that 
specifically labels the organelles based on their mem-
brane potential (ΔΨm). Loss of this potential, as a result 
of mitochondrial membrane permeabilization, will ren-
der the organelle undetectable and has been associated 
with cytochrome C release and cell death initiation [52, 
56]. During data analysis, such events could be detected 
as a reduction of the relative mitochondrial area. Fig-
ure 4 shows that all cell types, except the Neuro-2a cells, 
showed significant mitochondrial damage. Accordingly, 
the loss of ΔΨm following NP exposure has already been 
described in multiple studies for several NPs in cell types 
from various lineages and species [8, 9, 42]. In the NSC 
all IONP doses caused a decreased signal area, though 
the effect was only significant starting from 7 nM. In con-
trast, the affected cell lines (ReNcell, C17.2 and LA-N-
2) were significantly affected by all IONP doses. The 
effects were most outspoken in the ReNcells, closely fol-
lowed by the hNSC and mNSC. The mitochondria in the 
C17.2 and LA-N-2 cell lines were perturbed to a lesser 
extent. Notably, the human cell types were more severely 
affected than the murine counterpart. In addition, the 
neuroblastoma cell lines were most resilient on the mito-
chondrial level. In correspondence, Heerdt et  al. [57] 
have previously found mitochondria in transformed cells 
to be less sensitive to perturbation due to an intrinsically 
lower mitochondrial activity and higher ΔΨm.
IONP loading affects cell morphology
Lastly, we examined alterations in cell morphology fol-
lowing IONP exposure. Cell morphology is a convenient 
Fig. 4 Effects on the mitochondria labelled with Mitotracker® CMX-ROS in terms of the relative signal area representing the size of the mitochon-
drial compartment relative to the total cell area. Except for the Neuro-2a cell line, all cell types showed a significant decrease in mitochondrial area. 
Statistical significance is indicated when appropriate (*p < 0.05). NTC not treated control
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parameter, especially for neural cells given their intricate 
architecture [8]. Moreover, numerous NPs have been 
shown to alter cell morphology as a secondary effect of 
ROS induction or via direct interactions with elements 
of the cytoskeleton [58, 59]. In addition to the changes in 
the morphological appearance, certain cell functions that 
require signaling via these components can subsequently 
be impaired [59, 60]. Thus, subtle effects on cell morphol-
ogy can indirectly herald perturbation of cell function 
whereas severe morphological alterations, i.e. cell round-
ing and shrinking, can be interpreted in terms of cell 
death [47].
After staining the entire cell cytoplasm, the impact of 
IONP exposure on cell morphology was quantified via 
two parameters: cell area and cell circularity. The latter 
is applied as a measure of cell spreading and is a value 
between zero and one, where one represents a perfect 
sphere (Additional file 1). Although the extent of neurite 
outgrowth is often applied to evaluate the morphology 
of neural cells [61], this parameter was not selected for 
this work, as several cell types are not capable of forming 
neurites.
While only a significantly decreased cell area was 
noted for the C17.2 cell line, both a reduced cell area 
and an increase in circularity were observed in the 
NSC, ReNcells and Neuro-2a cells (Fig.  5; Additional 
file  1: Figure S8). Thus, the cells became both smaller 
and more spherical in a concentration-dependent fash-
ion (Fig.  6), which was most outspoken in the ReN-
cells. Such loss of specific morphological features and 
cell shrinking has already been described in numerous 
studies for multiple NPs and cell types [3, 8, 22, 42]. 
Since it is known that cell transformation or immor-
talization affects cell morphology, it is not surprising 
that morphology was also differentially affected in the 
various cell types. For instance the mNSCs were more 
strongly affected in terms of morphology whereas 
only minor effects were observed in the C17.2 or 
Neuro-2a cell line. Since stem cells have a more intri-
cate architecture in comparison to most cell lines, it 
was not surprising that the morphology of the former 
was impaired more extensively. Finally, as the LA-N-2 
cells tend to grow in clusters we evaluated effects on 
cell morphology in terms of the total cluster area and 
number of cells per cluster, which both showed a simi-
lar concentration-dependent decrease starting from 
3.5  nM IONPs. Since the decrease in cluster area was 
slightly more severe than the number of cells per clus-
ter, we concluded that the cell area also decreased with 
every dose tested. 
Fig. 5 IONP-induced alterations in cell area (grey bars) and cell circularity (orange lines) visualized after labelling of the cytoplasm with the Cell-
Mask™ Blue probe for the NSC, progenitor cell lines and murine neuroblastoma cell line. Cell circularity is a measure of cell spreading and is a value 
between zero and one, where one represents a perfect sphere. LA-N-2 cell morphology was analysed in terms of cluster area (grey bars) and num-
ber of cells per cluster (orange bars). A decreased cell area and increased cell circularity were detected in the NSC, ReNcell and Neuro-2a cell line. 
For the C17.2 cells only a diminution in cell area was detected. In the LA-N-2 cell line a reduction in cells per cluster and cluster size were observed. 
Statistical significance is indicated when appropriate (*p < 0.05), in black for the cell area and orange in case of the cell circularity (respectively clus-
ter area and cells per cluster in case of the LA-N-2 cell line). NTC not treated control
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Overall, we observed similar effects on cell morphol-
ogy (cell rounding and shrinking) in the various cell 
types in contrast to previously evaluated parameters. 
However, the exact trends and extent of the responses 
clearly differed. Importantly, these variations could not 
unequivocally be linked to one or a specific combination 
Fig. 6 Representative images of untreated mNSCs (a), ReNcells (c) and C17.2 cells (e) as well exposed to 70 nM IONP (b, d, f). The mNSCs are 
affected in terms of cell area and circularity. The altered circularity in the ReNcells is less outspoken as initial morphology is less complex. Only the 
cell area is affected in the C17.2 cells
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of responses observed for the other toxicity parameters 
investigated in this study, underscoring the cell type spe-
cific nature of the recorded toxicity profiles.
Multiparametric analysis reveals cell type‑specific toxicity 
profiles
In general, our data set reveals that each cell type reacted 
in a specific way to IONP exposure in terms of both 
extent and nature of the responses (Table 2). This could 
not have been deduced from the acute toxicity assess-
ment (Fig.  1) but became increasingly clear with every 
additionally evaluated parameter. Furthermore, the 
obtained profiles would likely become increasingly com-
plex with the addition of supplementary end points such 
as the influence on autophagy, induction of endoplasmic 
reticulum stress or genotoxicity. Note that it was not the 
primary objective of this study to unravel the underlying 
toxicity mechanisms. Hereto, additional experiments, 
for instance on the type of cell death or gene expression, 
should be performed. Instead, the aim was to clearly show 
the impact of both the species and the cell type, under its 
optimal cell culture conditions on the nanotoxicity pro-
file within one single study. We show that for 3 different, 
though related neural cell types (stem cells, immortal-
ized cells and cancer cells) the effects in the human cells 
were often more outspoken than the murine alternative. 
In addition, we found the NSC from each species to be 
more sensitive to IONP exposure than the cell lines.
The observed variations in cell responses can be 
explained in several possible ways. One may argue that 
variations in NP uptake in the various cell types will be 
an important factor. In this regard, dose heterogeneity 
at single cell level due to variations in NP uptake in the 
same population will also lead to response heterogene-
ity [62]. In addition, NP uptake is related to the colloi-
dal stability in the applied cell culture media. Although 
we did not evaluate the abovementioned parameters in 
detail, it was previously shown that PMA-coated NPs 
show good stability in biological media and that they are 
taken up well by various cell types [25, 63]. Besides the 
extent of NP uptake, we believe that the cellular response 
is strongly related to the intracellular NP processing. This 
will in part depend on the uptake pathway since the lat-
ter will co-determine the intracellular trafficking route 
and the ultimate intracellular location. Indeed, as previ-
ously mentioned when NPs are present in the acidic and 
degrading environment of the endo-lysosomes, stronger 
cytotoxicity is observed than when the NPs reside in the 
cytosol [45]. In addition, the variations in intrinsic cell 
properties, such as the anti-oxidative capacity, metabolic 
rate (e.g. Ca2+ homeostasis) and mitochondrial activity, 
are to a large extent accountable for the revealed diver-
gent toxicity profiles. Combined, these elements advo-
cate an in vitro toxicity profiling that takes intrinsic cell 
properties and variations in the studied cell population 
into account. Indeed, to understand the intrinsic cellular 
capacity to traffic and handle exogenous materials could 
be of key importance to anticipate NP-evoked effects.
Furthermore, our data indicate that it is imperative to 
apply multiparametric methods that look beyond live/
dead scoring. Notably, even when only minor variations 
could be detected in the cell viability, as for instance for 
the Neuro-2a and ReNcells, cellular homeostasis was 
distinctly altered. In addition, minor cell viability altera-
tions for the ReNcells did not imply that the cell home-
ostasis was not impaired. Accordingly, Ge et  al. [64] 
found IONPs to evoke important effects on cell func-
tion without affecting cell viability. Also, toxicity end-
points included in nanosafety screens should be carefully 
selected as some are more sensitive or indicative of the 
induced damage. An example of the latter is the use of 
cell area and circularity as parameters to describe altera-
tions in cell morphology. Although effects on cell circu-
larity occurred sooner, the impact on cell area was more 
outspoken and illustrative for the extent of the actual 
damage in cell types without a complex architecture. 
Finally, the safety of the coating should be investigated 
in further detail to determine its possible contribution to 
some of the observed effects.
Notably, we found that none of the cell types included 
in this work would be a suitable substitute for any other 
tested. In contrast, other groups did succeed in iden-
tifying a cell line alternative for primary cells based on 
similar cellular responses to NP exposure [12]. In such 
cases the use of those cell lines should be encouraged. 
However, the generalized use of cell lines should be 
approached with caution, especially when performing a 
detailed toxicity profiling to elucidate the mechanisms 
via which NPs alter cell homeostasis. Indeed, cell lines 
are not always ideal candidates for the analysis of cell 
function and may not be representative in terms of dis-
crete cell perturbation [19]. Thus, it would be fitting to 
select a cell type based on the expected exposure and/or 
Table 2 Cell type-specific nanotoxicity profiles induced 
by 24 h exposure to 70 nM IONPs
ROS Ca2+ Mitochondria Cell morphology
Area Circularity
hNSC ↓ ↑ ↓ ↓ ↑
mNSC ↑ ↓ ↓ ↓ ↑
ReNcell ↑ ↑ ↓ ↓ ↑
C17.2 ↓ ↑ ↓ ↓ =
LA-N-2 ↓ ↓ ↓ / /
Neuro-2a ↓ ↓ = ↓ ↑
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intended application of the NPs. We also propose to cau-
tiously apply non-human cell types since we, as well as 
several other groups, have observed notable interspecies 
variations [15, 16].
For screening purposes the selection of a proper cell 
type is a balancing act. Indeed, primary cells can suffer 
from several drawbacks like an often limited availabil-
ity, specific cultivation requirements, a limited life-span, 
and possible inter-batch and individual variations, which 
possibly limit the throughput [7, 12]. Hence, cell lines are 
still the preferred candidates when performing a large-
scale screening of numerous NPs. For this reason and 
because it is highly unlikely that one single cell type will 
emerge as a universal model, we strongly believe that 
the definition of a set of standard cell lines would con-
stitute a definite asset in standardizing nanosafety assess-
ments. Additionally, the use of multiple cell types should 
be encouraged as it was shown to enhance the predic-
tive power of in  vitro nanosafety assessments [65]. The 
selected cell types would preferably be known to mimic 
responses observed in primary cells and would ideally be 
thoroughly characterized in terms of their intrinsic prop-
erties in order to enhance our understanding of the NP-
induced effects.
Conclusions
In this work, we investigated the effect of both species 
and cell type related variations on NP-evoked responses 
in six related neural cell types via a multiparametric 
approach. Interestingly, the observed impact on cellular 
health varied widely in each cell type in terms of both the 
nature and extent of the analyzed effects and cell type-
specific nanotoxicity profiles were obtained. Hence, con-
clusions on the safety of a NP should preferably not be 
based on the evaluation of a single toxicity end point in 
a single cell type. We propose to rationally select a cell 
model based on the envisioned (biomedical) application 
and/or exposure scenario, especially when performing 
an extensive in  vitro toxicity assessment with the aim 
of unveiling mechanisms via which the NPs inflict cell 
injury. Finally, with regard to standardization of in vitro 
nanosafety evaluations, we strongly believe that for the 
safety screening of large sets of nanomaterials the selec-
tion of a set of standard cell types, representing relevant 




AuNPs, AgNPs and IONPs were synthesized and coated 
with the polymer poly(isobutylene-alt-maleic anhydride) 
grafted with dodecylamine (PMA), as described in Addi-
tional file  1. Following synthesis, the core diameter was 
measured using transmission electron microscopy. UV/
Vis spectroscopy was applied to evaluate the spectral 
characteristics of the NPs. With the combination of UV/
Vis spectroscopy and inductively coupled plasma mass 
spectrometry the concentrations of the dispersions were 
determined. Finally the hydrodynamic diameter and 
zeta-potential were measured using a Zetasizer Nano ZS 
(Malvern Instruments). Detailed information on the char-
acterization procedures is provided in Additional file 1.
Cell culture
All assays were performed on six neural cell types 
(Table  1): human and murine neural stem cells (hNSC 
and mNSC, Invitrogen and Millipore, Belgium), a human 
and mouse-derived progenitor cell line, respectively 
ReNcell (Millipore, Belgium) and C17.2 (Sigma, Bel-
gium), and finally a human neuroblastoma cell line (LA-
N-2, European Collection of Cell Cultures) as well as a 
murine counterpart (Neuro-2a, Sigma, Belgium). All cell 
types were cultured according to the supplier’s guide-
lines. Detailed information on the applied coatings and 
culture media compositions can be found in Additional 
file 1.
The cells were cultured at 37 °C in a humidified atmos-
phere completed with 5 % CO2. Cell medium was renewed 
every other day and cells were split after reaching 80  % 
confluency. Hereto, the cells were dissociated with 0.05 % 
trypsin–EDTA (Invitrogen, Belgium), after which the cells 
were centrifuged (4 min, 300 g), resuspended in fresh cul-
ture medium and seeded at appropriate densities.
Acute toxicity
All cell types were seeded at 25,000 cells per well in 
opaque 96-well plates and were allowed to settle over-
night. Thereafter the cells were incubated with 2.5, 5, 10, 
25, 50 and 100 nM of the AuNPs and AgNPs and 3.5, 7, 
14, 35, 70 and 140 nM of the IONPs during 24 h at 37 °C 
(5 % CO2). After 24 h NP incubation, the CellTiter-GLO® 
assay (Promega, Belgium) was performed according to 
the manufacturer’s instructions. In short, 100 µL of the 
assay buffer was added to each well. Plates were shaken 
during 2 min after which a 10-min incubation period was 
respected. Finally, the signal was measured using a Glo-
Max® 96 Microplate Luminometer (Promega, Belgium). 
Experiments were performed in triplicate and the data 
are represented as the mean ± the standard error to the 
mean (SEM).
High content imaging
For the multiparametric analysis, cells were seeded in 
24-well plates and were allowed to attach overnight. 
Optimal seeding cell densities were identified for each 
cell type individually. The optimal seeding density was 
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defined as the density that would result in an 80 % con-
fluent cell layer in the untreated control at the end point 
of the assay. In order to preserve the cell density/cell 
medium volume ratio for all cell types, we varied the lat-
ter according to the optimal cell seeding density (Table 3).
For the evaluation of effects on ROS production and 
[Ca2+]c 7, 14, 35, 70 and 140 nM IONP dispersions were 
applied, whereas for the effects on cell morphology and 
the mitochondria 3.5, 7, 14, 35 and 70  nM were tested 
as effects on cell function were expected to occur start-
ing from lower NP doses. As the volume of cell medium 
used for incubation was adjusted according to the cell 
density, the NP number/volume cell medium/cell num-
ber remained equal in all high content experiments. 
Similar to acute toxicity experiments, the cells were 
incubated with the IONPs during 24  h at 37  °C in an 
atmosphere containing 5 % CO2 after which staining and 
analysis were performed. This set of data is presented as 
mean ± SEM from to independent replicates.
Reactive oxygen species and cytoplasmic calcium levels
To allow detection of reactive oxygen species (ROS) the 
general ROS marker CellROX® green probe (Molecular 
Probes, Invitrogen, Belgium) was selected. The latter was 
combined with the Rhod-2 AM (Molecular Probes, Inv-
itrogen, Belgium), which becomes strongly fluorescent 
upon interaction with free Ca2+ in the cytoplasm. Fol-
lowing 24 h IONP incubation, the cells were labelled with 
both probes as described in Additional file 1.
Effect on mitochondrial health and cell morphology
The mitochondria were labelled with Mitotracker® 
CMX-ROS Red (Molecular Probes, Invitrogen, Belgium), 
which specifically accumulates in the mitochondria 
based on its membrane potential. To allow evaluation of 
cell morphology the HCS CellMask™ Blue probe (Molec-
ular Probes, Invitrogen, Belgium) was applied. Again, 
cells were labeled following 24  h of IONP exposure as 
explained in Additional file 1.
Statistics
Acute toxicity data are expressed as mean ± SEM (n = 3). 
IN Cell data are presented as mean values normalized 
against the untreated control ± SEM (n = 2). Statistical 
analysis was performed using one-way ANOVA com-
bined with post hoc Dunnett test.
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Table 3 Seeding densities and incubation volumes per well applied in the multiparametric analysis
hNSC mNSC ReNcell C17.2 LA‑N‑2 Neuro‑2a
Cell density 35,000 17,500 17,500 15,000 50,000 15,000
Volume (µL) 700 350 350 300 1000 300
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